KATHLEEN SENECA: Open Payments
NPI 1093018798 · HILLSBOROUGH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,208 in 104 payments from 15 companies in 2025. Trend: 2023 $13,835 · 2024 $13,459 · 2025 $9,208
Speaker / faculty: $3,850Travel & lodging: $3,105Food & beverage: $2,253
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $5,740 |
| ViiV Healthcare Company | 32 | $2,499 |
| Gilead Sciences, Inc. | 16 | $308 |
| Aimmune Therapeutics, Inc. | 7 | $233 |
| Merck Sharp & Dohme LLC | 8 | $133 |
| Insmed, Inc. | 4 | $66 |
| Melinta Therapeutics, LLC | 3 | $56 |
| PFIZER INC. | 3 | $47 |
| CSL Behring | 1 | $23 |
| Astellas Pharma US Inc | 1 | $22 |
Products named: MAVYRET, DOVATO, PIFELTRO, DALVANCE, ZENPEP, APRETUDE, EMBLAVEO, VOWST.
Industry payments across NJ — which companies pay providers there.
